2020 annual financial data
Capricor Therapeutics 2020 Operating margin
Direct answer
Operating margin was -4,412.56%.
Operating income was -13,689,971 USD and net income was -13,657,028 USD.
Operating cash flow was -10,054,810 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 310,250 USD
- Operating income
- -13,689,971 USD
- Net income
- -13,657,028 USD
- Operating cash flow
- -10,054,810 USD